Literature DB >> 27829881

Moyamoya disease in pregnancy and delivery planning: A case series and literature review.

Erica Weston1, Niharika Mehta2.   

Abstract

Moyamoya disease is a rare condition characterized by stenosis or occlusion of the intracranial internal carotid arteries leading to the development of fragile collateral vessels. Disruption of these vessels can lead to both ischemic and hemorrhagic strokes. As such, these patients are sensitive to changes in intracranial pressure and pose a challenge in pregnancy and delivery planning. Two cases of a parturients with moyamoya disease are presented, and the literature regarding safe method of delivery in similar patients is reviewed. The available evidence suggests that adequate anesthesia, and maintenance of hemodynamic status, takes precedence over the exact method of delivery in these patients. Cesarean delivery under epidural anesthesia can be a safe option for parturients with moyamoya disease, but an uncomplicated vaginal delivery, most often assisted with either vacuum or forceps, has also been frequently reported.

Entities:  

Keywords:  Neurology; cardiovascular; high-risk pregnancy; maternal-fetal medicine; physiology

Year:  2016        PMID: 27829881      PMCID: PMC5089343          DOI: 10.1177/1753495X16653548

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  17 in total

Review 1.  Epidural analgesia for labor and delivery.

Authors:  Joy L Hawkins
Journal:  N Engl J Med       Date:  2010-04-22       Impact factor: 91.245

2.  Vaginal delivery in pregnancy with Moyamoya disease: experience at a single institute.

Authors:  Hiroaki Tanaka; Shinji Katsuragi; Kayo Tanaka; Takekazu Miyoshi; Chizuko Kamiya; Naoko Iwanaga; Reiko Neki; Jun C Takahashi; Tomoaki Ikeda; Jun Yoshimatsu
Journal:  J Obstet Gynaecol Res       Date:  2014-10-27       Impact factor: 1.730

3.  The natural history of moyamoya in a North American adult cohort.

Authors:  Bradley A Gross; Rose Du
Journal:  J Clin Neurosci       Date:  2012-11-10       Impact factor: 1.961

4.  Pregnancy and delivery in moyamoya disease: results of a nationwide survey in Japan.

Authors:  Jun C Takahashi; Tomoaki Ikeda; Koji Iihara; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

5.  Vaginal Delivery under Epidural Analgesia in Pregnant Women with a Diagnosis of Moyamoya Disease.

Authors:  Kimitoshi Sato; Masaru Yamada; Toshiyuki Okutomi; Rie Kato; Nobuya Unno; Kiyotaka Fujii; Toshihiro Kumabe
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-03-21       Impact factor: 2.136

Review 6.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

7.  A retrospective chart review of the perinatal period in 22 pregnancies of 16 women with Moyamoya disease.

Authors:  Kotaro Fukushima; Yasuo Yumoto; Yukiko Kondo; Yasuyuki Fujita; Seiichi Morokuma; Kiyomi Tsukimori; Norio Wake
Journal:  J Clin Neurosci       Date:  2012-08-21       Impact factor: 1.961

Review 8.  Ischemic stroke in a postpartum patient: understanding the epidemiology, pathogenesis, and outcome of Moyamoya disease.

Authors:  Mariko L Ishimori; Stanley N Cohen; David S Hallegua; Franklin G Moser; Michael H Weisman
Journal:  Semin Arthritis Rheum       Date:  2006-02       Impact factor: 5.532

9.  Pregnancy outcomes in women with moyamoya disease: experiences at a single center in Korea.

Authors:  Yun Ji Jung; Min-A Kim; Ja-Young Kwon; Hyo Ryun Lee; Hee Young Cho; Yong Won Park; Young Han Kim
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

10.  Moyamoya disease and pregnancy: case reports and criteria for successful vaginal delivery.

Authors:  Kiguna Sei; Hidenori Sasa; Kenichi Furuya
Journal:  Clin Case Rep       Date:  2015-02-04
View more
  1 in total

Review 1.  Intracerebral Hemorrhage in Women: A Review with Special Attention to Pregnancy and the Post-Partum Period.

Authors:  Shahed Toossi; Asma M Moheet
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.